Purchase Order 36C25024P0819
Award Date 4/1/24
Potential Completion Date 6/30/25
Potential Value $201K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92130, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price purchase order awarded by the Department of Veterans Affairs Veterans Health Administration to Travere Therapeutics, Inc., a biopharmaceutical company, for the supply of CHENODAL 250MG. The potential value of the award is $236,500.00, with a completion date of September 30, 2022. The contract is not associated with any set-aside program. Travere Therapeutics, Inc. is a for-profit organization and manufacturer of goods that has received numerous federal contract...
- The Department of Veterans Affairs has awarded a $236,500.00 firm fixed price contract to Travere Therapeutics, Inc. to provide the pharmaceutical product Chenodal (chenodiol) 250mg. The contract has a period of performance through March 23, 2024 and was not set aside for any specific business category. Travere Therapeutics is a biopharmaceutical company that specializes in rare disease therapies and has received multiple awards from the VA and other government agencies to supply specialty...
- This is a firm fixed price purchase order awarded to Travere Therapeutics, Inc., a biopharmaceutical company specializing in rare disease therapies, by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) for the supply of the pharmaceutical product CHENODAL 250 MG 6 DOSES. The contract, which has a potential value of $236,500.00, has a completion date of December 30, 2022. Travere Therapeutics holds a General Services Administration (GSA) Schedule contract for...
- This federal contract award was issued by the Department of Veterans Affairs (VA) Veterans Health Administration to Travere Therapeutics, Inc. for the delivery of the pharmaceutical product Chenodal. The firm fixed price purchase order, valued at $189,200.00, has a completion date of September 30, 2022. Travere Therapeutics is a biopharmaceutical company that specializes in rare disease therapies and has received numerous federal contract awards from the VA and other agencies to supply...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 awarded a $236,500 firm fixed price purchase order to Travere Therapeutics, Inc. Travere Therapeutics, Inc. Division for the delivery of CHENODAL 250MG (CHENODIOL) pharmaceutical products. Performance will take place in Foster City, California over a one year period ending September 30, 2024. No subcontractors or set aside designations were indicated. This order for chenodiol, a medication...
- This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Travere Therapeutics, Inc., a biopharmaceutical company specializing in rare disease therapies. The contract, valued at $94,600.00, is for the delivery of the pharmaceutical product CHENDAL 250MG. The award is part of Travere's existing Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs with the VA, and the company also holds a $25 million Blanket Purchase Agreement (BPA) with the VA...
- This federal contract award was made by the Department of Veterans Affairs (VA) to Travere Therapeutics, Inc., a biopharmaceutical company specializing in rare disease therapies. The $212,584.00 firm fixed-price purchase order is for the delivery of pharmaceutical drugs, with a period of performance ending on September 30, 2025. Travere Therapeutics holds a Federal Supply Schedule (FSS) contract with the VA as well as two Blanket Purchase Agreements (BPAs) specifically covering the procurement...
- Travere Therapeutics, Inc. was awarded a $18,542.20 firm fixed price delivery order from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 to supply Thioproin pharmaceutical products. The delivery order was issued under Travere's Pharmaceuticals and Drugs GSA Schedule contract (FSS-61-IB) for products to be delivered to the VA medical facility located in San Diego, California by June 2024. No set-aside designation was applied to this...
- This is a federal contract award to Travere Therapeutics, Inc., a biopharmaceutical company, for the delivery of the pharmaceutical product Thiola 100 mg. The contract, valued at $11,125.32, was awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 5 (VISN 5) on August 26, 2024, with an ultimate completion date of August 27, 2024. The contract is a firm fixed price delivery order issued under Travere's Federal Supply Schedule (FSS) contract with the VA for...
- The Department of Veterans Affairs (VA) has awarded Travere Therapeutics, Inc. a firm fixed price delivery order to provide THIOLA 100 MG, a pharmaceutical product used to treat rare diseases affecting kidney and liver function. This award is issued against Travere's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract with the VA, which serves as the primary vehicle for these types of orders. The delivery order has a potential value of $11,125.32 and a completion date of...